Search research articles
Contact Us
Filters
Showing results (51-60 of 260) with videos related to
Page
of 26
Sort By:
Journal of Affective Disorders
|
June 22, 2007
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study
Eduard Vieta, Francesco Panicali, Iris Goetz, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 28, 2020
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Leona Bessonova, Kristine Ogden, Michael J Doane, et al.
Current Medical Research and Opinion
|
February 24, 2012
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder
Hideaki Katagiri, Yasushi Takita, Mauricio Tohen, et al.
The Journal of Clinical Psychiatry
|
January 12, 2005
Weight gain during treatment of bipolar I patients with olanzapine
John Hennen, Roy H Perlis, Gary Sachs, et al.
The International Journal of Neuropsychopharmacology
|
February 5, 2010
Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis
Jorge M Tamayo, Carlos A Zarate, Eduard Vieta, et al.
Neuropsychiatric Disease and Treatment
|
February 24, 2021
Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review
Michael J Doane, Kristine Ogden, Leona Bessonova, et al.
Journal of Affective Disorders
|
December 3, 2011
Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study
Hideaki Katagiri, Yasushi Takita, Mauricio Tohen, et al.
Current Medical Research and Opinion
|
May 26, 2021
The efficacy of cariprazine on function in patients with bipolar depression: a <i>post hoc</i> analysis of a randomized controlled trial
Eduard Vieta, Joseph R Calabrese, Jessica Whelan, et al.
Journal of Affective Disorders
|
October 29, 2005
Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data
Trisha Suppes, Eileen Brown, Leslie M Schuh, et al.
The Journal of Clinical Psychiatry
|
April 5, 2011
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone
David E Kemp, Ellyn Johnson, Wei V Wang, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 260) with videos related to
Sort By:
Page
of 26
Journal of Affective Disorders
|
June 22, 2007
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study
Eduard Vieta, Francesco Panicali, Iris Goetz, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 28, 2020
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Leona Bessonova, Kristine Ogden, Michael J Doane, et al.
Current Medical Research and Opinion
|
February 24, 2012
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder
Hideaki Katagiri, Yasushi Takita, Mauricio Tohen, et al.
The Journal of Clinical Psychiatry
|
January 12, 2005
Weight gain during treatment of bipolar I patients with olanzapine
John Hennen, Roy H Perlis, Gary Sachs, et al.
The International Journal of Neuropsychopharmacology
|
February 5, 2010
Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis
Jorge M Tamayo, Carlos A Zarate, Eduard Vieta, et al.
Neuropsychiatric Disease and Treatment
|
February 24, 2021
Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review
Michael J Doane, Kristine Ogden, Leona Bessonova, et al.
Journal of Affective Disorders
|
December 3, 2011
Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study
Hideaki Katagiri, Yasushi Takita, Mauricio Tohen, et al.
Current Medical Research and Opinion
|
May 26, 2021
The efficacy of cariprazine on function in patients with bipolar depression: a <i>post hoc</i> analysis of a randomized controlled trial
Eduard Vieta, Joseph R Calabrese, Jessica Whelan, et al.
Journal of Affective Disorders
|
October 29, 2005
Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data
Trisha Suppes, Eileen Brown, Leslie M Schuh, et al.
The Journal of Clinical Psychiatry
|
April 5, 2011
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone
David E Kemp, Ellyn Johnson, Wei V Wang, et al.
Page
of 26